|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 69,100.00 KRW | -2.40% |
|
-8.36% | -1.71% |
| 03-04 | Asian petchem makers face naphtha disruption as Iran conflict widens | RE |
| 02-25 | South Korea Approves Lotte-HD Hyundai Daesan Petrochemical Merger -- OPIS | DJ |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 1.13 | 4.54 | -1.92 | -0.75 | -1.62 | |||||
Return on Total Capital | 1.28 | 5.3 | -2.23 | -0.83 | -1.81 | |||||
Return On Equity % | 1.26 | 9.78 | 0.17 | -0.21 | -9.08 | |||||
Return on Common Equity | 1.22 | 9.87 | 0.43 | -0.33 | -11.44 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 9.31 | 13.52 | 1.2 | 3.83 | 1.53 | |||||
SG&A Margin | 5.32 | 4.28 | 3.88 | 4.66 | 4.89 | |||||
EBITDA Margin % | 9.72 | 13.07 | 0.83 | 4.08 | 1.99 | |||||
EBITA Margin % | 3.66 | 8.96 | -2.98 | -0.87 | -3.29 | |||||
EBIT Margin % | 2.92 | 8.47 | -3.42 | -1.8 | -4.32 | |||||
Income From Continuing Operations Margin % | 1.43 | 7.87 | 0.12 | -0.2 | -8.94 | |||||
Net Income Margin % | 1.3 | 7.43 | 0.28 | -0.25 | -8.37 | |||||
Net Avail. For Common Margin % | 1.3 | 7.43 | 0.28 | -0.25 | -8.37 | |||||
Normalized Net Income Margin | 1.31 | 6.17 | -0.63 | -1.53 | -2.85 | |||||
Levered Free Cash Flow Margin | 3.97 | 1.87 | -15.04 | -16.03 | -2.81 | |||||
Unlevered Free Cash Flow Margin | 4.52 | 2.17 | -14.62 | -14.84 | -1.52 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.62 | 0.86 | 0.9 | 0.66 | 0.6 | |||||
Fixed Assets Turnover | 1.6 | 2.37 | 2.35 | 1.54 | 1.31 | |||||
Receivables Turnover (Average Receivables) | 8.65 | 11 | 11.16 | 9.16 | 9.38 | |||||
Inventory Turnover (Average Inventory) | 6.85 | 7.2 | 8.24 | 7.17 | 7.16 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 2.39 | 2.06 | 1.48 | 1.5 | 1.06 | |||||
Quick Ratio | 1.8 | 1.4 | 0.94 | 0.96 | 0.67 | |||||
Operating Cash Flow to Current Liabilities | 0.46 | 0.32 | -0.03 | 0.12 | 0.18 | |||||
Days Sales Outstanding (Average Receivables) | 42.33 | 33.17 | 32.7 | 39.85 | 39.03 | |||||
Days Outstanding Inventory (Average Inventory) | 53.44 | 50.66 | 44.3 | 50.91 | 51.12 | |||||
Average Days Payable Outstanding | 30.28 | 27.35 | 26.8 | 27.07 | 23.91 | |||||
Cash Conversion Cycle (Average Days) | 65.49 | 56.48 | 50.19 | 63.68 | 66.25 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 24.6 | 23.72 | 36.63 | 49.5 | 53.35 | |||||
Total Debt / Total Capital | 19.74 | 19.18 | 26.81 | 33.11 | 34.79 | |||||
LT Debt/Equity | 15.38 | 12.22 | 13.94 | 28.89 | 26.66 | |||||
Long-Term Debt / Total Capital | 12.34 | 9.88 | 10.2 | 19.32 | 17.38 | |||||
Total Liabilities / Total Assets | 29.27 | 32.44 | 35.54 | 39.56 | 42.15 | |||||
EBIT / Interest Expense | 3.32 | 18.03 | -5.09 | -0.95 | -2.1 | |||||
EBITDA / Interest Expense | 11.03 | 27.81 | 1.23 | 2.15 | 0.97 | |||||
(EBITDA - Capex) / Interest Expense | 3.58 | 18.73 | -16.06 | -7.46 | -4.35 | |||||
Total Debt / EBITDA | 2.84 | 1.55 | 34.19 | 12.31 | 26.18 | |||||
Net Debt / EBITDA | -0.31 | -0.35 | 14.03 | 7.48 | 17.62 | |||||
Total Debt / (EBITDA - Capex) | 8.75 | 2.3 | -2.63 | -3.54 | -5.82 | |||||
Net Debt / (EBITDA - Capex) | -0.95 | -0.51 | -1.08 | -2.15 | -3.92 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -19.18 | 48.25 | 22.93 | -10.46 | 2.43 | |||||
Gross Profit, 1 Yr. Growth % | -40.21 | 115.23 | -89.06 | 185.38 | -59.08 | |||||
EBITDA, 1 Yr. Growth % | -35.33 | 99.36 | -92.19 | 339.64 | -49.92 | |||||
EBITA, 1 Yr. Growth % | -62.78 | 263.42 | -140.85 | -73.79 | 286.47 | |||||
EBIT, 1 Yr. Growth % | -67.7 | 330.06 | -149.68 | -52.91 | 145.88 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -79.58 | 713.01 | -98.03 | -241.06 | 4.55K | |||||
Net Income, 1 Yr. Growth % | -77.84 | 749.16 | -95.38 | -181.25 | 3.32K | |||||
Normalized Net Income, 1 Yr. Growth % | -80.6 | 596.17 | -112.74 | 106.92 | 90.18 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -80.6 | 749.16 | -95.37 | -166.53 | 3.28K | |||||
Accounts Receivable, 1 Yr. Growth % | -3.27 | 36.92 | 9.68 | 8.62 | -7.84 | |||||
Inventory, 1 Yr. Growth % | -7.3 | 79.37 | -8.75 | 9.92 | 0.6 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -4.1 | 4.79 | 41.97 | 32.4 | 12.49 | |||||
Total Assets, 1 Yr. Growth % | -3.28 | 17.97 | 17.19 | 24.98 | 3.21 | |||||
Tangible Book Value, 1 Yr. Growth % | -0.92 | 14.78 | 1.42 | -10.71 | -6.54 | |||||
Common Equity, 1 Yr. Growth % | -2.71 | 12.17 | 0.33 | 7.6 | -7.66 | |||||
Cash From Operations, 1 Yr. Growth % | 2.58 | 13.38 | -111.27 | -571.46 | 95.36 | |||||
Capital Expenditures, 1 Yr. Growth % | -10.08 | -3.62 | 235.25 | 40.4 | -38.51 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 202.72 | -29.99 | -1.09K | -4.55 | -82.06 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 139.1 | -28.88 | -929.28 | -9.08 | -89.51 | |||||
Dividend Per Share, 1 Yr. Growth % | -46.27 | 130.56 | -57.83 | 0 | -42.86 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -12.8 | 9.46 | 35 | 4.92 | -4.23 | |||||
Gross Profit, 2 Yr. CAGR % | -35.01 | 13.44 | -51.48 | -44.13 | 8.07 | |||||
EBITDA, 2 Yr. CAGR % | -32.81 | 13.54 | -60.54 | -41.4 | 48.38 | |||||
EBITA, 2 Yr. CAGR % | -53.06 | 16.3 | 21.84 | -67.28 | 0.64 | |||||
EBIT, 2 Yr. CAGR % | -57.17 | 17.86 | 46.17 | -51.63 | 7.61 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -66.89 | 28.86 | -60.17 | -83.34 | 710.06 | |||||
Net Income, 2 Yr. CAGR % | -68.32 | 37.19 | -37.66 | -80.63 | 426.98 | |||||
Normalized Net Income, 2 Yr. CAGR % | -65.07 | 16.4 | -6.23 | -47.48 | 98.38 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -67.89 | 28.35 | -37.57 | -82.45 | 374.46 | |||||
Accounts Receivable, 2 Yr. CAGR % | -3.08 | 15.09 | 22.55 | 9.15 | 0.05 | |||||
Inventory, 2 Yr. CAGR % | -6.4 | 28.95 | 27.94 | 0.16 | 5.16 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | -3.59 | 0.25 | 21.97 | 37.1 | 22.04 | |||||
Total Assets, 2 Yr. CAGR % | -3.46 | 6.82 | 17.54 | 21.03 | 13.58 | |||||
Tangible Book Value, 2 Yr. CAGR % | 1.31 | 6.64 | 7.84 | -4.84 | -8.65 | |||||
Common Equity, 2 Yr. CAGR % | 0.44 | 4.47 | 6.04 | 3.9 | -0.32 | |||||
Cash From Operations, 2 Yr. CAGR % | -2.57 | 7.84 | -64.26 | -27.11 | 203.48 | |||||
Capital Expenditures, 2 Yr. CAGR % | -34.08 | -6.9 | 79.76 | 116.96 | -7.09 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -10.3 | 45.58 | 162.86 | 206.93 | -58.61 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -0.14 | 30.4 | 142.85 | 174.59 | -69.12 | |||||
Dividend Per Share, 2 Yr. CAGR % | -41.45 | 11.3 | -1.4 | -35.06 | -24.41 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | -8.34 | 4.08 | 13.78 | 17.73 | 4.08 | |||||
Gross Profit, 3 Yr. CAGR % | -32.91 | -3.12 | -47.98 | -12.42 | -49.64 | |||||
EBITDA, 3 Yr. CAGR % | -31.03 | -3.45 | -53.48 | -11.86 | -44.39 | |||||
EBITA, 3 Yr. CAGR % | -47.08 | -7.14 | -17.94 | -27 | -25.49 | |||||
EBIT, 3 Yr. CAGR % | -50.42 | -7.59 | -11.63 | 0.21 | -16.83 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -57.5 | -3.77 | -68.12 | -39.29 | 8.9 | |||||
Net Income, 3 Yr. CAGR % | -58.67 | -5.19 | -55.83 | -31.9 | 8.65 | |||||
Normalized Net Income, 3 Yr. CAGR % | -56.26 | -5.18 | -44.48 | 23.95 | -19.35 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -58.7 | -4.34 | -57.71 | -36.23 | 1.4 | |||||
Accounts Receivable, 3 Yr. CAGR % | -4.58 | 8.75 | 13.26 | 17.72 | 3.16 | |||||
Inventory, 3 Yr. CAGR % | 0.46 | 16.26 | 14.91 | 21.63 | 0.3 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 3.6 | -0.88 | 12.58 | 25.35 | 28.35 | |||||
Total Assets, 3 Yr. CAGR % | -0.28 | 3.21 | 10.15 | 19.97 | 14.77 | |||||
Tangible Book Value, 3 Yr. CAGR % | 5.16 | 5.61 | 4.84 | 1.27 | -5.41 | |||||
Common Equity, 3 Yr. CAGR % | 3.79 | 4.21 | 3.04 | 6.56 | -0.11 | |||||
Cash From Operations, 3 Yr. CAGR % | -25.18 | 2.48 | -49.21 | -15.55 | 1.24 | |||||
Capital Expenditures, 3 Yr. CAGR % | -26.49 | -25.18 | 42.7 | 65.54 | 42.51 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -17.62 | -17.41 | 175.53 | 87.53 | 19.13 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -16.08 | -10.82 | 141.59 | 75.03 | -7.53 | |||||
Dividend Per Share, 3 Yr. CAGR % | - | -7.54 | -19.46 | -0.93 | -37.77 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 0.86 | 6.5 | 7.01 | 4.41 | 6.2 | |||||
Gross Profit, 5 Yr. CAGR % | -11.21 | -5.49 | -41.06 | -22.27 | -30.31 | |||||
EBITDA, 5 Yr. CAGR % | -10.75 | -5.69 | -44.83 | -20.93 | -26.01 | |||||
EBITA, 5 Yr. CAGR % | -22.64 | -9.07 | -26.12 | -38.82 | -10.96 | |||||
EBIT, 5 Yr. CAGR % | -26.01 | -9.61 | -23.59 | -28.67 | -4.39 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -29.27 | -4.95 | -58.59 | -52.36 | 16.28 | |||||
Net Income, 5 Yr. CAGR % | -30.71 | -6.02 | -51.28 | -49.86 | 19.06 | |||||
Normalized Net Income, 5 Yr. CAGR % | -30.09 | -6.7 | -40.62 | -25.26 | -6.76 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -30.95 | -6.35 | -51.28 | -51.54 | 11.22 | |||||
Accounts Receivable, 5 Yr. CAGR % | 6.67 | 5.11 | 5.46 | 8.91 | 7.78 | |||||
Inventory, 5 Yr. CAGR % | 6.02 | 13.59 | 10.66 | 9.53 | 10.91 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 13.5 | 7.13 | 10.59 | 12.86 | 16.27 | |||||
Total Assets, 5 Yr. CAGR % | 11.07 | 7.59 | 6.5 | 9.99 | 11.51 | |||||
Tangible Book Value, 5 Yr. CAGR % | 8.72 | 11.51 | 6.23 | 1.28 | -0.78 | |||||
Common Equity, 5 Yr. CAGR % | 11.29 | 9.01 | 4.68 | 4.07 | 1.68 | |||||
Cash From Operations, 5 Yr. CAGR % | -12.77 | -11.26 | -44.32 | -10.58 | 3.83 | |||||
Capital Expenditures, 5 Yr. CAGR % | 17.69 | -13.61 | 5.12 | 14.54 | 20.19 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -23.36 | -2.88 | 31.03 | 39.63 | 29.08 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -21.71 | -2.28 | 28.37 | 39.84 | 6.1 | |||||
Dividend Per Share, 5 Yr. CAGR % | - | - | - | -19.73 | -21.48 |
- Stock Market
- Equities
- A011170 Stock
- Financials Lotte Chemical Corporation
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















